UNIGE document Scientific Article
previous document  unige:106629  next document
add to browser collection
Title

Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries

Authors
Leblebicioglu, Hakan
Arends, Joop E
Ozaras, Resat
Corti, Giampaolo
Santos, Lurdes
Boesecke, Christoph
Ustianowski, Andrew
Duberg, Ann-Sofi
show hidden authors show all authors [1 - 27]
Published in Antiviral Research. 2018, vol. 150, p. 9-14
Abstract Treatment with direct acting antiviral agents (DAAs) has provided sustained virological response rates in >95% of patients with chronic hepatitis C virus (HCV) infection. However treatment is costly and market access, reimbursement and governmental restrictions differ among countries. We aimed to analyze these differences among European and Eurasian countries.
Identifiers
PMID: 29217468
Full text
Article (Published version) (449 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Etudes et traitement de l'hépatite C et B (554)
Citation
(ISO format)
LEBLEBICIOGLU, Hakan et al. Availability of hepatitis C diagnostics and therapeutics in European and Eurasia countries. In: Antiviral Research, 2018, vol. 150, p. 9-14. https://archive-ouverte.unige.ch/unige:106629

13 hits

0 download

Update

Deposited on : 2018-07-24

Export document
Format :
Citation style :